Published in Chest on January 01, 2001
Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ (2003) 3.92
Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ (2003) 3.73
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace (2009) 2.52
Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ (2012) 1.86
Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care. J Gen Intern Med (2005) 1.48
Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 1.39
Determination of the clinical importance of study results. J Gen Intern Med (2002) 1.34
Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial. CMAJ (2005) 1.22
Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial. CMAJ (2007) 1.03
Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation. J Gen Intern Med (2008) 1.01
Recent developments in atrial fibrillation. BMJ (2005) 0.97
New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness. Drug Des Devel Ther (2014) 0.92
Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart (2003) 0.92
Atrial fibrillation in the elderly. J Geriatr Cardiol (2012) 0.90
A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]. BMC Cardiovasc Disord (2004) 0.86
New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin. Br J Pharmacol (2005) 0.86
Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods. BMJ (2003) 0.86
Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation? Cardiovasc Ultrasound (2014) 0.85
The management of non-valvular atrial fibrillation (NVAF) in Australian general practice: bridging the evidence-practice gap. A national, representative postal survey. BMC Fam Pract (2008) 0.83
Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist (2008) 0.83
Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study. Thromb J (2005) 0.81
The impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study. Can J Cardiol (2007) 0.80
Randomized trials of rate vs. rhythm control for atrial fibrillation. J Interv Card Electrophysiol (2004) 0.80
Warfarin for non-valvar atrial fibrillation: still underused in the 21st century? Heart (2003) 0.80
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy. Intern Emerg Med (2007) 0.79
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation. Cardiol Ther (2016) 0.78
Improving outpatient warfarin use for hospitalized patients with atrial fibrillation. Pharm Pract (Granada) (2008) 0.78
Development of a tool to improve the quality of decision making in atrial fibrillation. BMC Med Inform Decis Mak (2011) 0.78
Atrial fibrillation anticoagulation care in a large urban family medicine practice. Can Fam Physician (2014) 0.77
Why is warfarin underutilized in patients with atrial fibrillation? J Interv Card Electrophysiol (2004) 0.77
Breaks in continuity of care and the rural senior transferred for medical care under regionalisation. Int J Integr Care (2003) 0.76
Atrial Fibrillation. Curr Treat Options Cardiovasc Med (2001) 0.75
Antithrombotic therapy in cardiac embolism. Curr Cardiol Rev (2010) 0.75
Stroke And Bleeding Risk Assessment: Where Are We Now? J Atr Fibrillation (2014) 0.75
Post mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation. J Interv Card Electrophysiol (2005) 0.75
Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism. Heart (2003) 0.75
A Review Of Clinical Trials On LARIAT Device. J Atr Fibrillation (2015) 0.75
Stroke prevention in patients with atrial fibrillation: the diagnosis and management of hypertension by specialists. Can J Cardiol (2006) 0.75
Evidence-based study on antithrombotic therapy in patients at risk of a stroke with paroxysmal atrial fibrillation. Exp Ther Med (2013) 0.75
Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation. Postgrad Med J (2005) 0.75
A practical approach to the management of patients with atrial fibrillation. Heart Asia (2010) 0.75
Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatran. Curr Control Trials Cardiovasc Med (2004) 0.75
The risk factors associated with postoperative hemorrhage after tooth extraction: a multi-center retrospective study of patients receiving oral antithrombotic therapy. Oral Maxillofac Surg (2017) 0.75
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med (1997) 9.85
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
The Canadian CT Head Rule for patients with minor head injury. Lancet (2001) 7.91
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA (2001) 7.48
Assessing health-related quality of life in patients with sciatica. Spine (Phila Pa 1976) (1995) 7.23
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol (1991) 6.55
Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA (1998) 6.34
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
Is it time to pull the pulmonary artery catheter? JAMA (1996) 5.69
The clinical information value of the glycosylated hemoglobin assay. N Engl J Med (1984) 4.79
Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med (2001) 4.73
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA (1999) 4.31
Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA (1986) 4.20
The Maine Lumbar Spine Study, Part III. 1-year outcomes of surgical and nonsurgical management of lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 4.11
The effect of enforcing tobacco-sales laws on adolescents' access to tobacco and smoking behavior. N Engl J Med (1997) 4.06
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med (1996) 3.86
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med (1993) 3.67
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science (1984) 3.47
Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45
Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med (1994) 3.33
Is integrative medicine the medicine of the future? A debate between Arnold S. Relman, MD, and Andrew Weil, MD. Arch Intern Med (1999) 3.33
A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation (1993) 3.31
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2007) 3.28
The Ottawa patient decision aids. Eff Clin Pract (1999) 3.22
Surgical and nonsurgical management of lumbar spinal stenosis: four-year outcomes from the maine lumbar spine study. Spine (Phila Pa 1976) (2000) 3.09
Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA (1998) 3.03
Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials (1999) 2.99
Evidence-based medicine and the practicing clinician. J Gen Intern Med (1999) 2.99
Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. Arch Intern Med (1998) 2.98
National patterns in the treatment of smokers by physicians. JAMA (1998) 2.94
Health care in America: the good, the bad, and the ugly. Arch Intern Med (2000) 2.92
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
The Maine Lumbar Spine Study, Part II. 1-year outcomes of surgical and nonsurgical management of sciatica. Spine (Phila Pa 1976) (1996) 2.91
Paradoxical embolism. Diagnosis during life. Am J Med (1972) 2.85
Natural history of pulmonary embolism. Prog Cardiovasc Dis (1975) 2.83
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81
Variation in emergency department use of cervical spine radiography for alert, stable trauma patients. CMAJ (1997) 2.79
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1992) 2.76
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest (2001) 2.72
Cholesterol and violent behavior. Arch Intern Med (1994) 2.64
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med (2001) 2.60
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ (1995) 2.50
Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med (1997) 2.48
Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg (1998) 2.44
Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med (2004) 2.42
The Quebec Task Force classification for Spinal Disorders and the severity, treatment, and outcomes of sciatica and lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 2.41
The rational clinical examination. Does this patient have a clinically important carotid bruit? JAMA (1993) 2.38
Unexplained chest pain in patients with normal coronary arteriograms: a follow-up study of functional status. N Engl J Med (1980) 2.33
Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med (1996) 2.29
Dictated versus database-generated discharge summaries: a randomized clinical trial. CMAJ (1999) 2.28
What is the quality of life for survivors of cardiac arrest? A prospective study. Acad Emerg Med (1999) 2.27
Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest (2001) 2.25
Initiating, conducting and maintaining guidelines development programs. CMAJ (1993) 2.24
Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med (1995) 2.22
Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med (1999) 2.21
Antithrombotic therapy in atrial fibrillation. Chest (1992) 2.21
A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med (1999) 2.19
Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18
Surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: five-year outcomes from the Maine Lumbar Spine Study. Spine (Phila Pa 1976) (2001) 2.17
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1998) 2.17
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09
Antithrombotic therapy in atrial fibrillation. Chest (1995) 2.08
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med (1999) 2.07
Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med (1990) 2.06
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol (1996) 2.03
Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA. Circulation (1999) 2.02
Rationing intensive care--physician responses to a resource shortage. N Engl J Med (1983) 2.00
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936. Bioorg Med Chem Lett (1999) 1.99
Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med (1991) 1.99
Long-term disability and return to work among patients who have a herniated lumbar disc: the effect of disability compensation. J Bone Joint Surg Am (2000) 1.95
Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study. Ann Intern Med (1998) 1.95
Atmospheric ozone: formation and effects on vegetation. Environ Pollut (1988) 1.94
Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Heart J (1988) 1.89
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes (1997) 1.88
Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med (2000) 1.88
Coronary arteries: breath-hold MR angiography. Radiology (1991) 1.86
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med (1991) 1.85
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA (2000) 1.83
Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med (1993) 1.83
Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82
The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med (1999) 1.78
National patterns of warfarin use in atrial fibrillation. Arch Intern Med (1997) 1.75
Sounding Board. CPR training for physicians. N Engl J Med (1980) 1.74
Stroke prevention in atrial fibrillation. BMJ (1997) 1.74
Patients with syncope admitted to medical intensive care units. JAMA (1982) 1.74
A bold proposal to achieve near-universal health care coverage in the United States. Arch Intern Med (2000) 1.71
Prospective navigator correction of image position for coronary MR angiography. Radiology (1997) 1.70
Double-oblique free-breathing high resolution three-dimensional coronary magnetic resonance angiography. J Am Coll Cardiol (1999) 1.70
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med (2001) 1.69
Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol (1998) 1.68
Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med (1998) 1.68
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest (1998) 1.67